Skip to content

Clinical trials

Phase 3 Heart Failure, Systolic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure, Systolic Phase: Phase 3 Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20111
20141
20161
20192
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated3
Not yet recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioCardia, Inc.1
Boston Scientific Corporation1
Dr. med. Mahir Karakas1
Göteborg University1
Hospital de Clinicas de Porto Alegre1
Novartis Pharmaceuticals1
Scios, Inc.1
Seoul National University Hospital1
Shahid Beheshti University of Medical Sciences1
Skane University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure, Systolic10
Heart Failure5
Iron Deficiencies2
Anemia1
Anemia, Iron-Deficiency1
Atrial Fibrillation1
Bundle-Branch Block1
Cardiovascular Diseases1
Endocrine System Diseases1
Erectile Dysfunction1

Trials

Showing 51 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.